Joint Formulary & PAD

Uridine triacetate - 5-Fluorouracil or capecitabine toxicity

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Granules
Associated Icons :
Restrictions / Comments :
Important
https://www.toxbase.org/

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Uridine triacetate
Indication :
5-Fluorouracil or capecitabine toxicity
Group Name :
Keywords :
Brand Names Include :
Important Information :
https://www.toxbase.org/ . Stock not held by Surrey Trusts. Available from regional centres. Refer to TOXBASE / NPIS for advice
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Uridine triacetate is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat 5-Fluorouracil or capecitabine toxicity.

  • No records returned.

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.